Roger M. Lyons

10.7k citations
131 papers · 8.9k · 3 hit papers · h-index 41

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Hematology top 0.2%
    • Platelet Disorders and Treatments
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation

Papers in

    • Platelet Disorders and Treatments 42
    • Acute Myeloid Leukemia Research 36
    • Multiple Myeloma Research and Treatments 13
    • Iron Metabolism and Disorders 4
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 19
    • Chronic Lymphocytic Leukemia Research 3

Roger M. Lyons

130 papers receiving 8.5k citations

Roger M. Lyons's Hit Papers

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial 2017 · 366 citations
3660+6+12Years since publication5001k1.5k

Peers

Roger M. Lyons
Comparison fields: 5 of 105
  • Internal Medicine 1k
  • Hematology 4.2k
  • Genetics 2.3k
  • Oncology 355
  • Toxicology 64
Replace Mohamad A. Hussein with:
Mohamad A. Hussein United States
Edward N. Libby United States
Sanford Jay Kempin United States
Kazuyuki Shimizu Japan
Rachid Baz United States
Wilson I. Gonsalves United States
David H. Irwin United States
Manisha Bhutani United States
Anna Marina Liberati Italy
Raman K. Desikan United States
Roger M. Lyons relative to Mohamad A. Hussein United States Mohamad A. Hussein's profile →
Citations per field
00.5×2×4×5.0×
Mohamad A. Hussein · 1×
Citations per year

Countries citing papers authored by Roger M. Lyons

Since Specialization
Citations

This map shows the geographic impact of Roger M. Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger M. Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger M. Lyons more than expected).

Fields of papers citing papers by Roger M. Lyons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger M. Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger M. Lyons. The network helps show where Roger M. Lyons may publish in the future.

Co-authors

The 25 scholars most cited alongside Roger M. Lyons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roger M. Lyons Line = papers co-authored together Roger M. Lyons links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Hit paper breakdown →
20121727
2
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
Hit paper breakdown →
2008712
3 2006438
4 2008366
5
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Hit paper breakdown →
2017366
6 2006326
7 2015257
8 2014243
9 2013233
10 1975227
11 2009227
12 2019216
13 2007200
14 2009165
15 2009159
16 2013135
17 2016130
18 2008122
19 2014118
20 1994112

About Roger M. Lyons

Roger M. Lyons is a scholar working on Hematology, Genetics, Internal Medicine, Pathology and Forensic Medicine and Biochemistry, having authored 131 papers that have together received 8.9k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (42 papers), Acute Myeloid Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Multiple Myeloma Research and Treatments (13 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Lymphoma Diagnosis and Treatment (5 papers), Iron Metabolism and Disorders (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Internal Medicine (1k citations), Hematology (4.2k citations), Genetics (2.3k citations), Oncology (355 citations) and Toxicology (64 citations). Roger M. Lyons has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include James Bruce Bussel, David J. Kuter, Janet Lee Nichol, James N. George, Matthew D. Guo, Philip W. Majerus, Nancy Stanford, Jeffrey S. Wasser, Vinod A. Pullarkat and Mikkael Aaron Sekeres. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia Research, Journal of Hematology & Oncology and The Lancet Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact